Biweekly administration of cetuximab in Japanese patients with recurrent or metastatic head and neck cancer Nobukazu TanakaTomohiro EnokidaMakoto Tahara Original Article 09 August 2022 Pages: 1669 - 1674
Real-world clinical outcomes in Japanese patients with locally advanced squamous cell carcinoma of the head and neck treated with radiotherapy plus cetuximab: a prospective observational study (JROSG12-2) Yosuke OtaTakeshi KodairaTetsuo Akimoto Original Article 24 August 2022 Pages: 1675 - 1683
miR-339-3p inhibits cell growth and epithelial–mesenchymal transition in nasopharyngeal carcinoma by modulating the KAT6A/TRIM24 axis Pei GaoKun ZhaoPeng Zhang Original Article 17 August 2022 Pages: 1684 - 1697
Predictive role of circulatory levels of high-mobility group box 1 for radiation pneumonitis in patients with non-small cell lung cancer treated with definitive thoracic radiotherapy Shoko IsoyamaKakuhiro YamaguchiNoboru Hattori Original Article 03 September 2022 Pages: 1698 - 1705
The utility of serum osteopontin levels for predicting postoperative complications after colorectal cancer surgery Kumiko SekiguchiAkihisa MatsudaHiroshi Yoshida Original Article 11 August 2022 Pages: 1706 - 1716
Long-term outcomes of D2 vs. D3 lymph node dissection for cT2N0M0 colorectal cancer: a multi‑institutional retrospective analysis Tadahiro KojimaHitoshi HinoKenichi Sugihara Original Article 27 August 2022 Pages: 1717 - 1724
Clinical effectiveness of surgical treatment after lenvatinib administration for hepatocellular carcinoma Shinji ItohKatsuya ToshidaTomoharu Yoshizumi Original Article 12 August 2022 Pages: 1725 - 1732
First-line pembrolizumab for patients with early relapsing urothelial carcinoma after perioperative chemotherapy: a retrospective analysis of bladder cancer and upper urinary tract cancer Nobutaka NishimuraMakito MiyakeKiyohide Fujimoto Original Article 27 August 2022 Pages: 1733 - 1741
Human papillomavirus testing and cytology using physician-collected uterine cervical samples vs. self-collected vaginal samples and urine samples Noriko TeradaMotoki MatsuuraTsuyoshi Saito Original Article 11 September 2022 Pages: 1742 - 1749
The ‘best friend effect’: a promising tool to encourage HPV vaccination in Japan Asami YagiYutaka UedaTadashi Kimura Original Article 03 September 2022 Pages: 1750 - 1757
Dedifferentiation in low-grade osteosarcoma: a Japanese Musculoskeletal Oncology Group (JMOG) study Toshihide HiraiHiroshi KobayashiSakae Tanaka Original Article 06 August 2022 Pages: 1758 - 1766
Clinical outcomes of brain metastasectomy from soft tissue and bone sarcomas: a systematic review Ying WangMegan DelisleAmirrtha Srikanthan Original Article 22 August 2022 Pages: 1767 - 1779
Usefulness of ultrasonography and elastography in diagnosing oxaliplatin-induced sinusoidal obstruction syndrome Rika SaitoYasuyuki KawamotoNaoya Sakamoto Original Article Open access 30 August 2022 Pages: 1780 - 1790
Letter to the Editor: Inflammation influences the prognosis of hepatocellular carcinoma Xiao LiuShunda Du Letter to the Editor 12 August 2022 Pages: 1791 - 1792
Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19) Kenjiro AogiKenichi WatanabeShinji Ohno Correction Open access 27 September 2022 Pages: 1793 - 1793
